These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22605964)

  • 1. Classification of HCV NS5B polymerase inhibitors using support vector machine.
    Wang M; Wang K; Yan A; Yu C
    Int J Mol Sci; 2012; 13(4):4033-4047. PubMed ID: 22605964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors.
    Wang M; Zhong M; Yan A; Li L; Yu C
    SAR QSAR Environ Res; 2014; 25(1):1-15. PubMed ID: 24283437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification models of HCV NS3 protease inhibitors based on support vector machine (SVM).
    Wang M; Xuan S; Yan A; Yu C
    Comb Chem High Throughput Screen; 2015; 18(1):24-32. PubMed ID: 25410306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    Mol Divers; 2011 Aug; 15(3):645-53. PubMed ID: 20931278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM).
    Qin Z; Wang M; Yan A
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2931-2938. PubMed ID: 28501513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminating of ATP competitive Src kinase inhibitors and decoys using self-organizing map and support vector machine.
    Yan A; Hu X; Wang K; Sun J
    Mol Divers; 2013 Feb; 17(1):75-83. PubMed ID: 23117252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors.
    Li Y; Kong Y; Zhang M; Yan A; Liu Z
    Mol Inform; 2016 Apr; 35(3-4):116-24. PubMed ID: 27491921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.
    May MM; Brohm D; Harrenga A; Marquardt T; Riedl B; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Antiviral Res; 2012 Aug; 95(2):182-91. PubMed ID: 22580131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
    Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
    Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.
    Musmuca I; Caroli A; Mai A; Kaushik-Basu N; Arora P; Ragno R
    J Chem Inf Model; 2010 Apr; 50(4):662-76. PubMed ID: 20225870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.
    Küçükgüzel I; Satılmış G; Gurukumar KR; Basu A; Tatar E; Nichols DB; Talele TT; Kaushik-Basu N
    Eur J Med Chem; 2013 Nov; 69():931-41. PubMed ID: 24161679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors.
    Malik AA; Phanus-Umporn C; Schaduangrat N; Shoombuatong W; Isarankura-Na-Ayudhya C; Nantasenamat C
    J Comput Chem; 2020 Jul; 41(20):1820-1834. PubMed ID: 32449536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition.
    Biswal BK; Wang M; Cherney MM; Chan L; Yannopoulos CG; Bilimoria D; Bedard J; James MN
    J Mol Biol; 2006 Aug; 361(1):33-45. PubMed ID: 16828488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review.
    Xie Y; Ogah CA; Jiang X; Li J; Shen J
    Curr Drug Targets; 2016; 17(13):1560-76. PubMed ID: 26648061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Organizing Map (SOM) and Support Vector Machine (SVM) Models for the Prediction of Human Epidermal Growth Factor Receptor (EGFR/ ErbB-1) Inhibitors.
    Kong Y; Qu D; Chen X; Gong YN; Yan A
    Comb Chem High Throughput Screen; 2016; 19(5):400-11. PubMed ID: 27074760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An objective assessment of conformational variability in complexes of hepatitis C virus polymerase with non-nucleoside inhibitors.
    Caillet-Saguy C; Simister PC; Bressanelli S
    J Mol Biol; 2011 Dec; 414(3):370-84. PubMed ID: 22008450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Origins of Hepatitis C Virus NS5B Polymerase Inhibitory Activity Using Machine Learning Approaches.
    Worachartcheewan A; Prachayasittikul V; Anuwongcharoen N; Shoombuatong W; Prachayasittikul V; Nantasenamat C
    Curr Top Med Chem; 2015; 15(18):1814-26. PubMed ID: 25961524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolones as HCV NS5B polymerase inhibitors.
    Kumar DV; Rai R; Brameld KA; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Shaghafi MB; Hu H; Lehoux I; To N; Young WB; Green MJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):82-7. PubMed ID: 21145235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using self-organizing map (SOM) and support vector machine (SVM) for classification of selectivity of ACAT inhibitors.
    Wang L; Wang M; Yan A; Dai B
    Mol Divers; 2013 Feb; 17(1):85-96. PubMed ID: 23124952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.